Template:CCQuickRef: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{#vardefine:weight|2}}{{#vardefine:age|0}} | |||
==[[Critical Care Quick Reference]] Group== | ==[[Critical Care Quick Reference]] Group== | ||
{{Dosing Variables}} | {{Dosing Variables}} | ||
| Line 126: | Line 127: | ||
| align="center" style="background:#f0f0f0;"|'''Dose''' | | align="center" style="background:#f0f0f0;"|'''Dose''' | ||
| align="center" style="background:#f0f0f0;"|'''Calculation''' | | align="center" style="background:#f0f0f0;"|'''Calculation''' | ||
| | {{#ifexpr: {{#var:age}}>8| | ||
<tr> | |||
| | <td> [[D50W]] </td><td> 50mL (1 amp) </td><td> {{#var:d50w}} mL/kg</td> | ||
</tr> | |||
}} | |||
{{#ifexpr: {{#var:age}}>2| | |||
<tr> | |||
<td> D25W </td><td> {{#expr:{{#var:weight}}*{{#var:d25}} }}mL</td><td> {{#var:d25}} mL/kg </td> | |||
</tr> | |||
}} | |||
|- | |- | ||
| D10 W ||{{#expr:{{#var:weight}}*{{#var:d10}} }}mL || {{#var:d10}} mL/kg | | D10 W ||{{#expr:{{#var:weight}}*{{#var:d10}} }}mL || {{#var:d10}} mL/kg | ||
Revision as of 13:40, 30 March 2015
Critical Care Quick Reference Group
| kg | 2 |
| Age | 0 years |
| Broselow Color | Green |
Normal Vital Signs
| Heart Rate | 75 |
| Respiratory Rate | 18 |
| Systolic BP | >90 |
Intubation
| Medication | Dose | Calculation |
| Pretreatment | ||
|---|---|---|
| Lidocaine | 3 mg | 1.5 mg/kg[1] |
| Fentanyl | 2 mcg | 1 mcg/kg |
| Atropine | 0.04 mg | 0.02 mg/kg |
| RSI | ||
| Etomidate | 0.6 mg | 0.3 mg/kg |
| Succinylcholine | 3 mg | 1.5 mg/kg |
| Midazolam (Versed) | 0.2 mg | 0.1 mg/kg |
| Ketamine | 4 mg | 2 mg/kg |
| Vecuronium | 0.2 mg | 0.1 mg/kg |
| Rocuronium | 2 mg | 1 mg/kg |
| Equipment | ||
| ET Tube (cuffed) | 3 | cuffed: age/4+3 uncuffed: age/4+4 |
| Blade | 1 | Miller or MAC |
| cm to teeth | 9 | 3 x ETT size |
Pulseless Arrest
| Medication | Dose | Calculation |
| Defibrilation First Shock | 4 J | 2 J/kg |
| Defibrilation Second Shock | 8 J | 4 J/kg |
| Epinephrine (1:10,000) | 0.02 mg | 0.01 mg/kg |
| Amiodarone load (without pulse) | 10 mg | 5 mg/kg |
| Lidocaine | 2 mg | 1 mg/kg |
| Lidocaine Infusion | 100 mcg/min | 50 mcg/kg/min |
| Magnesium sulfate | 100 mg | 50 mg/kg |
| CalCl (100mg/mL) | 40 mg | 20 mg/kg |
Cardiac with Pulse
| Medication | Dose | Calculation |
| Adenosine | 0.2 mg | 0.1 mg/kg |
| Adenosine Repeat | 0.4 mg | 0.2 mg/kg |
| Amiodarone load (with pulse) | 10 mg | 5 mg/kg |
| Amiodarone 2nd/3rd dose | repeat loading dose up to total 3 times | 15 mg/kg max |
| Atropine | 0.04 mg | 0.02 mg/kg |
| Cardioversion First Shock | 2 J | 1 J/kg |
| Cardioversion Second Shock | 4 J | 2 J/kg |
| Procainamide | 30 mg | 15 |
| Diltiazem | 0.5 mg | 0.25 mg/kg |
| Esmolol | 200 mcg | 100 mcg/kg/min |
| Magnesium sulfate | 100 mg | 50 mg/kg |
| Nitroglycerin drip | 0.1 mcg | 0.05 mcg/kg/min |
| Glucagon | 0.05 mg | 0.025 mg/kg |
Hypoglycemia
| Medication | Dose | Calculation
|
| D10 W | 5mL | 2.5 mL/kg |
| Glucagon | 0.05mg | 0.025 mg/kg |
Vasopressors
| Medication | IV Dose (mcg/kg/min) | Concentration |
| Norepinephrine (Levophed) | 0.1-2 mcg/kg/min | 8mg in 500mL D5W |
| Dopamine | 2-20 mcg/kg/min | 400mg in 250 D5W |
| Dobutamine | 2-20 mcg/kg/min | 250mg in 250 mg D5W |
| Epinephrine | 0.1-1 mcg/kg/min | 1mg in 250 D5W |
Sedation
| Medication | Dose | Calculation |
| Lorazepam (Ativan) | 0.1 mg | 0.05 mg/kg |
| Morphine | 0.2 mg | 0.1 mg/kg |
| Fenatnyl | 2 mcg | 1 mcg/kg |
| Ketamine | 2 mg | 1 mg/kg |
| Midazolam (Versed) | 0.1 mg | 0.05 mg/kg |
| Propofol IV (initial) | 2 mg | 1 mg/kg |
| Propofol (drip) | 100 mcg | 50 mcg/kg/min |
Seizure and CNS
| Medication | Dose | Calculation |
| Lorazepam (Ativan) | 1.75 mg | 0.05 mg/kg |
| Fosphenytoin (PE = phenytoin equivalent | 40 PE | 20 PE/kg |
| Phenytoin (Dilantin) | 40 mg | 20 mg/kg |
| Phenobarbitol | 20 mg | 10 mg/kg |
| Diazepam (Valium) rectal | 0.2 mg | 0.1 mg/kg every 2 min |
| Mannitol | 2 g | 1 mg/kg |
| Hypoglycemia | IV dextrose | see glucose table |
- ↑ Robinson N, Clancy M. Emerg Med J. 2001 Nov; 18(6): 453–457. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature doi:10.1136/emj.18.6.453 PMCID:PMC1725712
